🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Mairs and Power’s AMGN Holdings & Trades

First Buy
Q2 2013
Duration Held
51 Quarters
Largest Add
Q2 2013
+11,505 Shares
Current Position
5,524 Shares
$1.81 M Value

Mairs and Power's AMGN Position Overview

Mairs and Power (via Mairs & Power INC) currently holds 5,524 shares of Amgen Inc. (AMGN) worth $1.81 M, representing 0.02% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.

Based on 13F filings since 2013, Mairs and Power has maintained a long-term strategic position in AMGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2018, adding 1,985 shares. Largest reduction occurred in Q2 2024, reducing 1,335 shares.

Analysis based on 13F filings available since 2013 Q2

Mairs and Power's Amgen (AMGN) Holding Value Over Time

Track share changes against reported price movement

Quarterly Amgen (AMGN) Trades by Mairs and Power

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 -143 Reduce 2.52% 5,524 $327.31
Q3 2025 -171 Reduce 2.93% 5,667 $282.20
Q2 2025 +877 Add 17.68% 5,838 $279.21
Q1 2025 -646 Reduce 11.52% 4,961 $311.55
Q4 2024 -341 Reduce 5.73% 5,607 $260.64
Q3 2024 -2 Reduce 0.03% 5,948 $322.21
Q2 2024 -1,335 Reduce 18.33% 5,950 $312.45
Q1 2024 -180 Reduce 2.41% 7,285 $284.32
Q4 2023 -10 Reduce 0.13% 7,465 $288.02
Q3 2023 -162 Reduce 2.12% 7,475 $268.76
Q2 2023 -1,117 Reduce 12.76% 7,637 $222.02
Q1 2023 -145 Reduce 1.63% 8,754 $241.75
Q4 2022 -36 Reduce 0.40% 8,899 $262.64
Q3 2022 -58 Reduce 0.64% 8,935 $225.41
Q2 2022 +301 Add 3.46% 8,993 $243.30
Q1 2022 +125 Add 1.46% 8,692 $241.83
Q4 2021 -63 Reduce 0.73% 8,567 $224.93
Q3 2021 +250 Add 2.98% 8,630 $212.63
Q2 2021 -75 Reduce 0.89% 8,380 $243.79
Q1 2021 -35 Reduce 0.41% 8,455 $248.85
Q4 2020 +35 Add 0.41% 8,490 $229.92
Q3 2020 +75 Add 0.89% 8,455 $254.17
Q4 2019 -400 Reduce 4.56% 8,380 $241.05
Q2 2019 -300 Reduce 3.30% 8,780 $184.28
Q1 2019 -243 Reduce 2.61% 9,080 $189.98
Q4 2018 -250 Reduce 2.61% 9,323 $194.68
Q3 2018 -646 Reduce 6.32% 9,573 $207.25
Q2 2018 +271 Add 2.72% 10,219 $184.56
Q1 2018 +1,985 Add 24.93% 9,948 $170.49
Q4 2017 -166 Reduce 2.04% 7,963 $173.93
Q3 2017 -555 Reduce 6.39% 8,129 $186.49
Q2 2017 -161 Reduce 1.82% 8,684 $172.27
Q1 2017 -1,071 Reduce 10.80% 8,845 $164.05
Q1 2016 -1,175 Reduce 10.59% 9,916 $149.96
Q4 2015 -75 Reduce 0.67% 11,091 $162.29
Q3 2015 +275 Add 2.53% 11,166 $138.28
Q2 2015 -50 Reduce 0.46% 10,891 $153.52
Q3 2014 -50 Reduce 0.45% 10,941 $140.48
Q2 2014 +211 Add 1.96% 10,991 $118.37
Q4 2013 -400 Reduce 3.58% 10,780 $114.10
Q3 2013 -325 Reduce 2.82% 11,180 $111.90
Q2 2013 +11,505 Add 0.00% 11,505 $98.65

Mairs and Power's Amgen Investment FAQs

Mairs and Power first purchased Amgen Inc. (AMGN) in Q2 2013, acquiring 11,505 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Mairs and Power has held Amgen Inc. (AMGN) for 51 quarters since Q2 2013.

Mairs and Power's largest addition to Amgen Inc. (AMGN) was in Q2 2013, adding 11,505 shares worth $1.14 M.

According to the latest 13F filing for Q4 2025, Mairs and Power's firm, Mairs & Power INC, owns 5,524 shares of Amgen Inc. (AMGN), valued at approximately $1.81 M.

As of the Q4 2025 filing, Amgen Inc. (AMGN) represents approximately 0.02% of Mairs and Power's publicly disclosed stock portfolio, making it one of their key holdings.

Mairs and Power's peak holding in Amgen Inc. (AMGN) was 11,505 shares, as reported at the end of Q2 2013.